Skip to main content

EcoR1 Capital, LLC's Form 4 filing

Adaptimmune Therapeutics PLC (ADAPY) · filed Jul 30, 2025

Accession no.
0000935836-25-000476
Filed
Jul 30, 2025, 6:20 PM ET
Trade date
Jul 28-30, 2025
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
EcoR1 Capital, LLCCIK 000158711410% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 28, 2025Ordinary SharesSSaleDisposed−33,931,740$0.1125F4−$3,817,320.75130,492,680IndirectPrice outlier
Jul 29, 2025Ordinary SharesSSaleDisposed−2,687,460$0.1012F7−$271,970.95127,805,220IndirectPrice outlier
Jul 30, 2025Ordinary SharesSSaleDisposed−27,433,338$0.1021F7−$2,800,943.81100,371,882IndirectPrice outlier

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F4

The price reported in Column 4 is the price per ADS sold by the reporting persons. This price is a weighted average price. These ADSs were sold in multiple transactions at prices ranging from $0.1086 to $0.1184, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of ADSs sold at each separate price within the ranges set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F7

The price reported in Column 4 is the price per ADS sold by the reporting persons.

Referenced by the price of 2 transactions in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)